OPRK1 and major depressive disorder: Activation of the KOR is viewed as a promising strategy for the treatment of pain, itch and epilepsy, whereas receptor blockade is associated with potential therapeutic effects in mood (depression and anxiety) and addictive disorders [16,17,18,19,20,21].